CLGN CollPlant Biotechnologies

NASDAQ
$3.91

CollPlant Biotechnologies (CLGN) SEC Filings

Everything CLGN has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

23 filings
Date Form Filing
6-K Material Agreement · Other
6-K Other
6-K Other
6-K Executive Change · Restructuring
6-K Material Agreement
144
6-K Capital Raise
6-K Capital Raise
SCHEDULE 13G
SCHEDULE 13D/A
6-K Other
6-K Acquisition Disposition · Capital Raise · Earnings Release · Executive Change · Guidance Update · Material Agreement · Other
6-K Other Reg Fd
6-K Acquisition Disposition · Delisting
6-K Acquisition Disposition · Investor Presentation
4
4
6-K Acquisition Disposition · Executive Change
6-K Acquisition Disposition
6-K Acquisition Disposition · Delisting · Other
6-K Acquisition Disposition · Executive Change · Material Agreement
SCHEDULE 13D/A
6-K

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.